These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 9829537)
1. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions. Touraine RL; Vahanian N; Ramsey WJ; Blaese RM Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537 [TBL] [Abstract][Full Text] [Related]
2. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
4. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117 [TBL] [Abstract][Full Text] [Related]
6. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
7. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea. Boucher PD; Ostruszka LJ; Shewach DS Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133 [TBL] [Abstract][Full Text] [Related]
8. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan. Wildner O; Blaese RM; Morris JC Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896 [TBL] [Abstract][Full Text] [Related]
9. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene. Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
11. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
12. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Colombo BM; Benedetti S; Ottolenghi S; Mora M; Pollo B; Poli G; Finocchiaro G Hum Gene Ther; 1995 Jun; 6(6):763-72. PubMed ID: 7548276 [TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA increases the bystander effect of herpes simplex virus thymidine kinase/ganciclovir gene therapy via enhanced gap junctional intercellular communication. Xiao J; Zhang G; Qiu P; Liu X; Wu Y; Du B; Li J; Zhou J; Li J; Tan Y PLoS One; 2013; 8(7):e67662. PubMed ID: 23861780 [TBL] [Abstract][Full Text] [Related]
14. [All-trans retinoic acid augments the bystander effect of herpes simplex virus thymidine kinase/ganciclovir system in the treatment of tongue carcinoma cell line]. Wang AX; Huang HZ Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):24-6. PubMed ID: 12760771 [TBL] [Abstract][Full Text] [Related]
15. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908 [TBL] [Abstract][Full Text] [Related]